An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms
Condition(s):Schizophrenia, Treatment-ResistantLast Updated:July 21, 2023Not yet recruiting